BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32241597)

  • 1. CDH1 mutations in gastric cancers are not associated with family history.
    Choi S; Jang J; Heo YJ; Kang SY; Kim ST; Lee J; Kang WK; Kim JW; Kim KM
    Pathol Res Pract; 2020 May; 216(5):152941. PubMed ID: 32241597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
    Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
    Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
    Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V
    PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
    Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
    Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
    Kheirollahi M; Saneipour M; Moridnia A
    J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer.
    Moridnia A; Tabatabaiefar MA; Zeinalian M; Minakari M; Kheirollahi M; Moghaddam NA
    J Gastrointest Cancer; 2019 Sep; 50(3):420-427. PubMed ID: 29577179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presymptomatic identification of CDH1 germline mutation in a healthy korean individual with family history of gastric cancer.
    Choi HJ; Ki CS; Suh SP; Kim JW
    Ann Lab Med; 2014 Sep; 34(5):386-9. PubMed ID: 25187893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
    Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
    J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population.
    Yamada H; Shinmura K; Ito H; Kasami M; Sasaki N; Shima H; Ikeda M; Tao H; Goto M; Ozawa T; Tsuneyoshi T; Tanioka F; Sugimura H
    Cancer Sci; 2011 Oct; 102(10):1782-8. PubMed ID: 21777349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature.
    Corso G; Marrelli D; Pascale V; Vindigni C; Roviello F
    BMC Cancer; 2012 Jan; 12():8. PubMed ID: 22225527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of a case of Helicobacter pylori-uninfected intramucosal gastric cancer in a family with hereditary diffuse gastric cancer.
    Funakoshi T; Miyamoto S; Kakiuchi N; Nikaido M; Setoyama T; Yokoyama A; Horimatsu T; Yamada A; Torishima M; Kosugi S; Yamada H; Sugimura H; Haga H; Sakai Y; Ogawa S; Seno H; Muto M; Chiba T
    Gastric Cancer; 2019 Jul; 22(4):892-898. PubMed ID: 30542785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
    BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing.
    Nemtsova MV; Kalinkin AI; Kuznetsova EB; Bure IV; Alekseeva EA; Bykov II; Khorobrykh TV; Mikhaylenko DS; Tanas AS; Kutsev SI; Zaletaev DV; Strelnikov VV
    Sci Rep; 2020 Jan; 10(1):504. PubMed ID: 31949278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
    Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
    Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.
    Corso G; Pedrazzani C; Pinheiro H; Fernandes E; Marrelli D; Rinnovati A; Pascale V; Seruca R; Oliveira C; Roviello F
    Eur J Cancer; 2011 Mar; 47(4):631-9. PubMed ID: 21106365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
    Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
    Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.